pLX313-TP53-WT Citations (7)

Originally described in: Mutational processes shape the landscape of TP53 mutations in human cancer.
Giacomelli AO, Yang X, Lintner RE, McFarland JM, Duby M, Kim J, Howard TP, Takeda DY, Ly SH, Kim E, Gannon HS, Hurhula B, Sharpe T, Goodale A, Fritchman B, Steelman S, Vazquez F, Tsherniak A, Aguirre AJ, Doench JG, Piccioni F, Roberts CWM, Meyerson M, Getz G, Johannessen CM, Root DE, Hahn WC Nat Genet. 2018 Oct;50(10):1381-1387. doi: 10.1038/s41588-018-0204-y. PubMed Journal

---

Articles Citing pLX313-TP53-WT

Articles
Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive Cancers. Leiendecker L, Neumann T, Jung PS, Cronin SM, Steinacker TL, Schleiffer A, Schutzbier M, Mechtler K, Kervarrec T, Laurent E, Bachiri K, Coyaud E, Murali R, Busam KJ, Itzinger-Monshi B, Kirnbauer R, Cerroni L, Calonje E, Rutten A, Stubenrauch F, Griewank KG, Wiesner T, Obenauf AC. Cancer Discov. 2023 Jan 9;13(1):70-84. doi: 10.1158/2159-8290.CD-22-0489. PubMed
A Novel TP53 Gene Mutation Sustains Non-Small Cell Lung Cancer through Mitophagy. Wang Y, Goh KY, Chen Z, Lee WX, Choy SM, Fong JX, Wong YK, Li D, Hu F, Tang HW. Cells. 2022 Nov 13;11(22):3587. doi: 10.3390/cells11223587. PubMed
Characterization of the interaction between the tumour suppressor p53 and heme and its role in the protein conformational dynamics studied by various spectroscopic techniques and hydrogen/deuterium exchange coupled with mass spectrometry. Vavra J, Sergunin A, Pompach P, Savchenko D, Hranicek J, Sloufova I, Shimizu T, Martinkova M. J Inorg Biochem. 2023 Jun;243:112180. doi: 10.1016/j.jinorgbio.2023.112180. Epub 2023 Mar 9. PubMed
Genetic heterogeneity in p53-null leukemia increases transiently with spindle assembly checkpoint inhibition and is not rescued by p53. Wang M, Phan S, Hayes BH, Discher DE. Chromosoma. 2024 Jan;133(1):77-92. doi: 10.1007/s00412-023-00800-y. Epub 2023 May 31. PubMed
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas. Liu S, Chai T, Garcia-Marques F, Yin Q, Hsu EC, Shen M, Shaw Toland AM, Bermudez A, Hartono AB, Massey CF, Lee CS, Zheng L, Baron M, Denning CJ, Aslan M, Nguyen HM, Nolley R, Zoubeidi A, Das M, Kunder CA, Howitt BE, Soh HT, Weissman IL, Liss MA, Chin AI, Brooks JD, Corey E, Pitteri SJ, Huang J, Stoyanova T. Cell Rep Med. 2024 Feb 20;5(2):101381. doi: 10.1016/j.xcrm.2023.101381. Epub 2024 Jan 19. PubMed
TEX264 drives selective autophagy of DNA lesions to promote DNA repair and cell survival. Lascaux P, Hoslett G, Tribble S, Trugenberger C, Anticevic I, Otten C, Torrecilla I, Koukouravas S, Zhao Y, Yang H, Aljarbou F, Ruggiano A, Song W, Peron C, Deangeli G, Domingo E, Bancroft J, Carrique L, Johnson E, Vendrell I, Fischer R, Ng AWT, Ngeow J, D'Angiolella V, Raimundo N, Maughan T, Popovic M, Milosevic I, Ramadan K. Cell. 2024 Oct 3;187(20):5698-5718.e26. doi: 10.1016/j.cell.2024.08.020. Epub 2024 Sep 11. PubMed
MAPK14/p38alpha shapes the molecular landscape of endometrial cancer and promotes tumorigenic characteristics. Joseph S, Zhang X, Droby GN, Wu D, Bae-Jump V, Lyons S, Mordant A, Mills A, Herring L, Rushing B, Bowser JL, Vaziri C. Cell Rep. 2025 Jan 28;44(1):115104. doi: 10.1016/j.celrep.2024.115104. Epub 2024 Dec 20. PubMed

If you have published an article using this material, please email us at to have your article added to this page.